Rubric Capital Management (New York)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
257,669
+200,998
| +355% | +$13.1M | 0.25% | 53 |
|
|
2025
Q1 | $3.79M | Hold |
56,671
| – | – | 0.07% | 59 |
|
|
2024
Q4 | $3.13M | Hold |
56,671
| – | – | 0.04% | 63 |
|
|
2024
Q3 | $3.38M | Sell |
56,671
-547,129
| -91% | -$32.6M | 0.06% | 58 |
|
|
2024
Q2 | $38.4M | Sell |
603,800
-354,733
| -37% | -$22.6M | 1.01% | 38 |
|
|
2024
Q1 | $66.3M | Sell |
958,533
-166,467
| -15% | -$11.5M | 1.96% | 18 |
|
|
2023
Q4 | $62M | Buy |
1,125,000
+277,989
| +33% | +$15.3M | 1.29% | 11 |
|
|
2023
Q3 | $49.2M | Hold |
847,011
| – | – | 1.84% | 18 |
|
|
2023
Q2 | $45.6M | Buy |
847,011
+198,970
| +31% | +$10.7M | 1.95% | 22 |
|
|
2023
Q1 | $25.7M | Buy |
648,041
+271,909
| +72% | +$10.8M | 0.67% | 36 |
|
|
2022
Q4 | $15.1M | Buy |
376,132
+89,086
| +31% | +$3.58M | 0.66% | 44 |
|
|
2022
Q3 | $9.23M | Buy |
287,046
+204,602
| +248% | +$6.58M | 0.46% | 46 |
|
|
2022
Q2 | $2.45M | Buy |
+82,444
| New | +$2.45M | 0.13% | 75 |
|
|
2022
Q1 | – | Sell |
-307,557
| Closed | -$14.2M | – | 71 |
|
|
2021
Q4 | $14.2M | Buy |
+307,557
| New | +$14.2M | 0.67% | 42 |
|